A Three-microRNA Signature Predicts Responses to Platinum-Based Doublet Chemotherapy in Patients with Lung Adenocarcinoma

PURPOSE: To examine the clinical utility of intratumor microRNAs (miRNA) as a biomarker for predicting responses to platinum-based doublet chemotherapy in patients with recurring lung adenocarcinoma (LADC). EXPERIMENTAL DESIGN: The expression of miRNAs was examined in LADC tissues surgically resecte...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Cancer Res
Auteurs principaux: Saito, Motonobu, Shiraishi, Kouya, Matsumoto, Kenji, Schetter, Aaron J., Ogata-Kawata, Hiroko, Tsuchiya, Naoto, Kunitoh, Hideo, Nokihara, Hiroshi, Watanabe, Shun-ichi, Tsuta, Koji, Kumamoto, Kensuke, Takenoshita, Seiichi, Yokota, Jun, Harris, Curtis C., Kohno, Takashi
Format: Artigo
Langue:Inglês
Publié: 2014
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6329384/
https://ncbi.nlm.nih.gov/pubmed/25142144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-14-1096
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires